您搜索了: turquoise (马耳他语 - 英语)

demografiji ewlenin f’ turquoise-iii
main demographics in turquoise-iii

svr12 għal individwi bi ko-infezzjoni ta’ hiv-1 fi turquoise-i
svr12 for hiv-1 co-infected subjects in turquoise-i

turquoise-iii: prova klinika ta’ individwi infettati bi gt1b b’ ċirrożi mingħajr rbv.
turquoise-iii: clinical trial of gt1b-infected subjects with cirrhosis without rbv

turquoise-ii–individwi b’ ġenotip 1, li qatt ma ħadu kuraqabel jew esperjenzaw peginterferon+ribavirin b’ċirrożi kkumpensata
turquoise-ii– genotype 1, treatment-naïve or peginterferon+ribavirin-experienced subjects with compensated cirrhosis

turquoise-iii: naïve għall-kura jew bl-esperjenza ta’ pegifn+rbv, b’ċirrożi kkumpensata
turquoise-iii: treatment-naïve or pegifn + rbv-experienced with compensated cirrhosis

fi provi kliniċi (turquoise-i) li kienu open-label is-sigurtà u l-effikaċja ta’ 12 jew 24 ġimgħa ta’ kura b’exviera u ombitasvir/paritaprevir/ritonavir u ribavirin kienu evalwati f’63 individwu b’ ko- infezzjoni tal-epatite Ċ kronika tal-ġenotip 1 ma’ hiv-1.
in an open-label clinical trial (turquoise-i) the safety and efficacy of 12 or 24 weeks of treatment with exviera and ombitasvir/paritaprevir/ritonavir and ribavirin was evaluated in 63 subjects with genotype 1 chronic hepatitis c co-infected with hiv-1.